Q2 2016 Holdings
Filed 2016-08-12 | 156 holdings | $227.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $108.9M | 450,533 | 47.9% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $50.9M | 653,845 | 22.4% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $13.5M | 243,995 | 6.0% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $12.1M | 1,389,370 | 5.3% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $11.8M | 363,585 | 5.2% |
| Cellectis S.A.(CLLS) | Sponsored ADS | 15117K103 | $8.3M | 310,250 | 3.6% |
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $7.7M | 756,090 | 3.4% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $3.7M | 304,472 | 1.6% |
| BeiGene Ltd.(ONC) | Sponsored ADR | 07725L102 | $3.5M | 116,707 | 1.5% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $2.4M | 296,934 | 1.1% |
| Allscripts Healthcare Solutions, Inc.(MDRX) | Common | 01988P108 | $2.2M | 173,600 | 1.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $209.5K | 2,511,731 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $138.0K | 1,398,789 | 0.1% |
| Allergan plc | Common | G0177J108 | $107.2K | 463,886 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $88.9K | 1,033,503 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $79.6K | 681,805 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $70.4K | 880,461 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $59.3K | 683,704 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $53.9K | 154,266 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $52.2K | 1,483,291 | 0.0% |
| Illumina Inc.(ILMN) | Common | 452327109 | $52.1K | 371,364 | 0.0% |
| Amgen Inc.(AMGN) | Common | 031162100 | $50.5K | 331,740 | 0.0% |
| UnitedHealth Group, Inc.(UNH) | Common | 91324P102 | $46.8K | 331,100 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $46.0K | 797,597 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $40.9K | 337,312 | 0.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $39.6K | 502,567 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $37.5K | 953,500 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $37.1K | 201,713 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $34.9K | 767,022 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | ADR | 881624209 | $33.8K | 671,958 | 0.0% |
| Mylan NV | Shares | N59465109 | $31.2K | 722,552 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $30.0K | 693,844 | 0.0% |
| AmerisourceBergen Corporation(COR) | Common | 03073E105 | $29.9K | 376,500 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $26.8K | 537,901 | 0.0% |
| HCA Holdings, Inc.(HCA) | Common | 40412C101 | $25.8K | 334,998 | 0.0% |
| The Medicines Company | Common | 584688105 | $23.7K | 704,238 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $23.3K | 129,300 | 0.0% |
| Jazz Pharmaceuticals plc(JAZZ) | Shares | G50871105 | $22.1K | 156,451 | 0.0% |
| Agilent Technologies, Inc.(A) | Common | 00846U101 | $22.0K | 495,450 | 0.0% |
| CVS Caremark Corporation(CVS) | Common | 126650100 | $21.4K | 223,891 | 0.0% |
| GlaxoSmithKline plc | Sponsored ADR | 37733W105 | $18.8K | 434,200 | 0.0% |
| Universal Health Services, Inc.(UHS) | Class B | 913903100 | $18.1K | 134,680 | 0.0% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $17.3K | 574,000 | 0.0% |
| Spdr S&P Biotech ETF(XBI) | S&P Biotech | 78464A870 | $15.9K | 294,000 | 0.0% |
| Medivation, Inc. | Common | 58501N101 | $15.5K | 256,638 | 0.0% |
| Corsicanto Ltd | Note 3.50% 1/15/32 | 220480AB3 | $14.9K | $14,700,000 | 0.0% |
| Ishares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $14.8K | 57,670 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $14.0K | 170,100 | 0.0% |
| Omega Healthcare Investors Inc.(OHI) | Common | 681936100 | $14.0K | 413,116 | 0.0% |
| Medical Properties Trust, Inc.(MPT) | Common | 58463J304 | $14.0K | 920,393 | 0.0% |